Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors

High densities of serotonergic 5-HT1A receptors, in excess of adult levels, were found in the human fetal brain between the 16th and 22nd weeks of gestation, 5-HT1A receptors were measured by quantitative autoradiography using brain sections of fetuses aborted at gestational ages 16-22 weeks. The highest receptor concentrations were detected in the cortex and hippocampus. Two brains obtained from fetuses with Down's syndrome at 22 and 24 weeks gestation exhibited abnormal receptor levels compared to age matched controls. The presence of an early, prenatal peak of 5-HT1A receptors in fetal cortex and hippocampus suggests that these receptors play a role in human brain development and may also be involved in developmental disorders such as Down's syndrome.

[1]  S. Kater,et al.  Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. , 1984, Science.

[2]  A. Biegon,et al.  Autoradiographic Analysis of [3H]Imipramine Binding in the Human Brain Postmortem: Effects of Age and Alcohol , 1988, Journal of neurochemistry.

[3]  E. Azmitia,et al.  Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons , 1989, Brain Research.

[4]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[5]  Anat Biegon,et al.  Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.

[6]  R. O'brien,et al.  Abnormalities of 5‐hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome , 1971, The Journal of physiology.

[7]  U. Spampinato,et al.  Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development , 1987, International Journal of Developmental Neuroscience.

[8]  J. Coyle,et al.  Transient postnatal elevation of serotonin levels in mouse neocortex. , 1988, Brain research.

[9]  A. Biegon,et al.  Quantitative receptor autoradiography with tritium-labeled ligands: comparison of biochemical and densitometric measurements , 1984, Journal of Neuroscience Methods.

[10]  C. Epstein The Neurobiology of Down syndrome , 1986 .

[11]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[12]  D. Cox,et al.  Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome. , 1988, Science.

[13]  O. Elroy-Stein,et al.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn‐superoxide dismutase activity. , 1989, The EMBO journal.

[14]  S. Snyder,et al.  Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Snyder,et al.  Characterization and localization of serotonin receptors in human brain postmortem , 1986, Brain Research.

[17]  E. Azmitia,et al.  Postnatal changes in serotonin1 receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin1 receptors , 1987 .

[18]  Distribution of serotonin-1A receptors in the monkey and the postmortem human hippocampal region. A quantitative autoradiographic study using the selective agonist [3H]8-OH-DPAT , 1986, Neuroscience Letters.

[19]  J. Voogd,et al.  The human central nervous system , 1978 .